For research use only. Not for therapeutic Use.
IMGN779 is an antibody-drug conjugate (ADC) targeting CD33. It exhibits promising therapeutic approaches in acute myeloid leukemia (AML). MW :146.48 KD.
| Catalog Number | I047314 |
| Purity | ≥95% |
| Reference | [1] Kovtun Y, et al. Mol Cancer Ther. 2018 Jun;17(6):1271-1279. |
